← Back to Clinical Trials
Recruiting NCT06171919

NCT06171919 Improving HIV Care Continuum Outcomes Among Formerly Incarcerated Individuals Through Critical Time Legal Interventions

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06171919
Status Recruiting
Phase
Sponsor University of Central Florida
Condition HIV
Study Type INTERVENTIONAL
Enrollment 100 participants
Start Date 2024-10-05
Primary Completion 2026-07-01

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 100 Years
Study Type INTERVENTIONAL
Interventions
Organizational PartnershipsHIV Continuum Care

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 100 participants in total. It began in 2024-10-05 with a primary completion date of 2026-07-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The purpose of this research is to better understand the impact of receiving legal aid on HIV care continuum outcomes among formerly incarcerated individuals. In addition, the investigators would like to assess the effectiveness of a comprehensive training for providers in increasing knowledge about medical legal partnerships and improving clinic level outcomes, including communication among providers. The training includes several topics including health disparities impacting formerly incarcerated individuals, health-harming legal needs and risks, screening for health-harming legal needs and risks, medical-legal partnership structure and operations, prerequisites for MLPs, embedding legal expertise within regularized case management, co-location of legal services, and data collection and analysis.

Eligibility Criteria

Inclusion Criteria: * 18 years or older * Living with HIV (as confirmed by medical record) * HIV viral load of more than 200 copies/mL (as confirmed by medical record) * Report history of incarceration * Willing and able to consent to participate in the trial (including accessing their medical records at the health care organization) * No intent to relocate within the 6 months following their enrollment in the study. Exclusion Criteria: * Individuals who self-report having been sentenced to serve under state or federal custody, with a sentence to begin within 6 months from proposed enrollment in the study

Contact & Investigator

Central Contact

Omar Martinez, JD, MPH, MS

✉ omar.martinez@ucf.edu

📞 4072668742

Frequently Asked Questions

Who can join the NCT06171919 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 100 Years, studying HIV. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06171919 currently recruiting?

Yes, NCT06171919 is actively recruiting participants. Contact the research team at omar.martinez@ucf.edu for enrollment information.

Where is the NCT06171919 trial being conducted?

This trial is being conducted at Orlando, United States.

Who is sponsoring the NCT06171919 clinical trial?

NCT06171919 is sponsored by University of Central Florida. The trial plans to enroll 100 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology